| 
               
            
                
                    
                        | 
                         Volume 4, Issue 2 
                         | 
                        
                         January 20, 2011 
                         | 
                     
                
             
            Reduce your risk of  
            breast  cancer by 30% 
            When women go through menopause,  the symptoms often seem unbearable. So doctors rarely hesitate to prescribe the  quickest fix. Unfortunately, this quick fix can kill you. In fact, a new study suggests  that this fix can increase your risk of breast cancer by 30%. And it can double your risk of death. 
            This quick fix, of course, is  the synthetic hormone PremPro. PremPro is the most commonly prescribed drug  given to women for menopausal symptom relief. It is a combination of synthetic  estrogens and a drug called medroxyprogesterone. It’s not really a hormone, but  a drug that alters your body’s chemistry and, as a result, reduces menopausal  symptoms. 
            The authors of this new study  followed 16,608 women. They were all part of the huge Women's Health Initiative  Study. In this part of the study, the researchers gave half of the women  PremPro. The other half took a placebo.  
Continued Below... 
Can You Restore Your Hearing by Taking Nutrients? 
Most doctors don't think nutrition has anything to do  with hearing loss. But several new studies show just how important nutrition is  to your ears - and how some people are actually reversing their hearing loss. 
Click Here To Learn More 
 
            The women took their  prescription for an average time of 5.6 years. And the researchers monitored  the women for an additional 7.9 years on average. What they found was nothing  short of startling. 
            The PremPro group ended up  having almost 30% more cases of breast cancer than the placebo group. The  cancers were also more likely to spread. The cancers spread to the lymph nodes  about 50% more often in the PremPro group. And, as I mentioned earlier, it gets  worse. The death rate from breast cancer in the PremPro group was more than  double that of the placebo group. 
            The authors published these  results in the Journal of the American  Medical Association, a very prestigious journal. So doctors shouldn’t  ignore it – but they probably will. 
            If you are taking PremPro or the  generic equivalent, stop it. Tell your doctor that you want a bio-identical  hormone combination of estradiol, estriol, and progesterone. A recent study on  using this bio-identical combination on 85,000 women for eight years shows no  increased risk of breast cancer. And they work as well as — or even better —  than the synthetic hormones. 
            It’s too bad for Big Pharma,  because they can't get a patent on bio-identicals (they’re natural). But  they’re good for you. You can learn all about the many benefits of taking  bio-identical hormones on my website. 
            Finding your Real Cures, 
              
                          Frank Shallenberger, MD 
            REF: Chlebowski RT, Anderson GL, Gass  M, et al. Estrogen plus progestin and breast cancer incidence and mortality in  postmenopausal women. JAMA. 2010 Oct 20;304(15):1684-92. 
             
            Copyright 2011 Soundview Publishing, LLC 
            If someone forwarded you this email, and you'd like to receive your own Real Cures Alert, please sign up on our website: www.secondopinionnewsletter.com 
            We have a strict anti-spam policy. We know how important your privacy is to you. That's why we do not share your email address with anyone. 
             
            Click here to read our Privacy Policy 
            To contact us:  
            Real Cures 
            PO Box 8051 
            Norcross, GA 30091-8051 
            800-610-5605 
            770-399-5617 
            [email protected] 
            Real Cures Health Alert is a complimentary e-mail service from Real Cures Newsletter written by Dr. Frank Shallenberger. 
            To unsubscribe from future mailings, please follow this link to manage your email preferences. 
             |